✦ LIBER ✦

PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND

✍ Scribed by K Kolasa; M Niewada; J Puelles Fernandez de Troconiz; R Townsend; P McEwan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB44 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ W Erhardt; K Bergenheim; R Townsend; J Puelles Fernandez de Troconiz; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB9 Cost-Effectiveness Analysis of Saxa

✍ E.E. Arinina; M. Rashyd 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDB27 THE COST-EFFECTIVENESS OF INSULIN

✍ J Walczak; W Dardzinski; M Kusy; J Lis; G Nogas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PDB18 THE RELATIVE COST EFFECTIVENESS OF

✍ P McEwan; N Mehin; AP Tetlow; P Sharplin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PDB19 THE RELATIVE COST EFFECTIVENESS OF

✍ P McEwan; N Mehin; AP Tetlow; P Sharplin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB